Clinical trial services provider, Oximio, announced in March that Peter Szabados has been appointed as the Chief Operating Officer (COO), joining the leadership team to enhance the client-focused operation.
“We are excited to bring Peter on board to benefit from his impressive experience and operational expertise,” said Krisztina Varga, Chief Executive Officer. “Peter’s role will be to lead and foster a client-focused and solution-oriented operation, and to help Oximio evolve to the next stage on the journey of becoming the first-choice for the provision of clinical trials services.”
“Throughout my career I have always worked to create something new. Oximio has had a very impressive track record of development since it was founded, and I believe it has a huge potential. I am happy and excited to become part of the team that will take Oximio to the next level.” – said Peter Szabados.
Szabados brings a wealth of international leadership experience. In the past 20+ years, Peter worked for market leading, global logistics service providers in several operations management positions before becoming a Managing Director. Lately, he has had global responsibilities in logistics innovation, non-conventional supply chain product development and turnaround projects. His cross-vertical experience has a track record in implementations, business turnaround, change management and process optimization through collaborative relationships. Peter is of a cosmopolitan mindset, his resumé includes working in multiple countries and holding regional and global roles.